Triptolide Protects Against Ischemic Stroke in Rats

Inflammation

Volumn 38, Issue 4, 2015, Pages 1617-1623

  Hao, Maolin ^a   Li, Xianghua ^b   Feng, Jianli ^a   Pan, Ning ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b People's Hospital of Jinan Central District   (China)

Author keywords

experimental stroke; rats; triptolide

Indexed keywords

EVANS BLUE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PROPIDIUM IODIDE; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; WATER; DITERPENE; EPOXIDE; NEUROPROTECTIVE AGENT; PHENANTHRENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; BRAIN WATER CONTENT; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL EXTRAVASATION; EXPERIMENTAL STROKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MTT ASSAY; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; RAT; WATER CONTENT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STROKE; TUMOR CELL LINE;

RATTUS;

ANIMALS; BRAIN ISCHEMIA; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; HUMANS; MALE; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84937251185     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0137-x     Document Type: Article

References (26)

1. Donnan, G.A., M. Fisher, M. Macleod, and S.M. Davis. 2008. Stroke. Lancet 371: 1612–1623.
2. Pietrzak, E., C. Cotea, and S. Pullman. 2014. Using commercial video games for upper limb stroke rehabilitation: is this the way of the future? Topics in Stroke Rehabilitation 21: 152–162.
3. Muir, K.W., P. Tyrrell, N. Sattar, and E. Warburton. 2007. Inflammation and ischaemic stroke. Current Opinion in Neurology 20: 334–342.
4. Lambertsen, K.L., K. Biber, and B. Finsen. 2012. Inflammatory cytokines in experimental and human stroke. Journal of Cerebral Blood Flow and Metabolism 32: 1677–1698.
5. Liu, Q. 2012. Triptolide and its expanding multiple pharmacological functions. International Immunopharmacology MCAOl 11: 377–383.
6. Zhao, G., L.T. Vaszar, D. Qiu, L. Shi, and P.N. Kao. 2000. Anti-inflammatory effects of triptolide in human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 279: L958–L966.
7. Tengchaisri, T., R. Chawengkirttikul, N. Rachaphaew, V. Reutrakul, R. Sangsuwan, and S. Sirisinha. 1998. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Letters 133: 169–175.
8. Hoyle, G.W., C.I. Hoyle, J. Chen, W. Chang, R.W. Williams, and R.J. Rando. 2010. Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 298: L830–L836.
9. Kang, B.T., R.F. Leoni, and A.C. Silva. 2014. Impaired CBF regulation and high CBF threshold contribute to the increased sensitivity of spontaneously hypertensive rats to cerebral ischemia. Neuroscience 269: 223–231.
10. Lee, H.F., T.S. Lee, and Y.R. Kou. 2012. Anti-inflammatory and neuroprotective effects of triptolide on traumatic brain injury in rats. Respiratory Physiology & Neurobiology 182: 1–8.
11. Minematsu, K., L. Li, C.H. Sotak, M.A. Davis, and M. Fisher. 1992. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 23: 1304–1310.
12. Vakili, A., F. Hosseinzadeh, and T. Sadogh. 2007. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia. Brain Research 1170: 97–102.
13. Cipolla, M.J., S.L. Chan, J. Sweet, M.J. Tavares, N. Gokina, and J.E. Brayden. 2014. Postischemic reperfusion causes smooth muscle calcium sensitization and vasoconstriction of parenchymal arterioles. Stroke 45: 2425–2430.
14. Chamorro, A., and J. Hallenbeck. 2006. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37: 291–293.
15. Tuttolomondo, A., D. Di Raimondo, R. Pecoraro, V. Arnao, A. Pinto, and G. Licata. 2012. Inflammation in ischemic stroke subtypes. Current Pharmaceutical Design 18: 4289–4310.
16. Sandhu, H., C.B. Xu, and L. Edvinsson. 2010. Upregulation of contractile endothelin type B receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via activation of MAPK. Toxicology and Applied Pharmacology MCAOl 249: 25–32.
17. Chen, Z.B., D.Q. Huang, F.N. Niu, X. Zhang, E.G. Li, and Y. Xu. 2010. Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB. Journal of Cerebral Blood Flow and Metabolism 30: 1356–1365.
18. Harari, O.A., and J.K. Liao. 2010. NF-κB and innate immunity in ischemic stroke. Annals of the New York Academy of Sciences 1207: 32–40.
19. Desai, A., N. Singh, and R. Raghubir. 2010. Neuroprotective potential of the NF-κB inhibitor peptide IKK-NBD in cerebral ischemia-reperfusion injury. Neurochemistry International 57: 876–883.
20. Nito, C., H. Kamada, H. Endo, K. Niizuma, D.J. Myer, and P.H. Chan. 2008. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. Journal of Cerebral Blood Flow and Metabolism 28: 1686–1696.
21. Liu, Q. 2011. Triptolide and its expanding multiple pharMCAOlogical functions. International Immunopharmacology MCAOl 12: 377–383.
22. Wong, K.F., Y. Yuan, and J.M. Luk. 2012. Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. Clinical and Experimental Pharmacology MCAOl Physiology 12: 311–320.
23. Tao, X., J.J. Cush, M. Garret, and P.E. Lipsky. 2001. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. Journal of Rheumatology 12: 2160–2167.
24. Tao, X., J. Younger, F.Z. Fan, B. Wang, and P.E. Lipsky. 2002. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis and Rheumatism 12: 1735–1743.
25. Kizelsztein, P., S. Komarnytsky, and I. Raskin. 2009. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. Journal of Neuroimmunology 12: 28–37.
26. Wu, Y., J. Cui, X. Bao, S. Chan, D.O. Young, D. Liu, and P. Shen. 2006. Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage. International Journal of Molecular Medicine 12: 141–150.